Cyngn Inc. Form 8-K Summary
Business Context and Reporting Period
Cyngn Inc. (Nasdaq: CYN), an emerging growth company incorporated in Delaware, filed this Current Report on Form 8-K on June 30, 2025, regarding events occurring on June 27, 2025. The filing details the entry into a material definitive agreement for a registered direct offering of equity securities.
Key Financial Metrics and Transaction Details
- Offering Structure: Sale of 313,564 shares of Common Stock at $7.50 per share and 1,979,769 Pre-Funded Warrants at $7.49999 per warrant.
- Net Proceeds: Approximately $14.7 million received after deducting estimated offering expenses and placement agent fees.
- Use of Proceeds: Designated for general corporate purposes, including working capital.
- Outstanding Shares: 7,039,266 shares of Common Stock issued and outstanding immediately following the issuance of Shares and shares issued upon exercise of certain Pre-Funded Warrants.
- Placement Agent Fees: Aegis Capital Corp. received a cash fee of 7% of aggregate gross proceeds plus expense reimbursement.
- Tail Provisions: Obligation to pay a former placement agent a cash fee of $1,204,000 and warrants to purchase 160,533 shares (exercise price $9.375, five-year term).
Note: This filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics for the company's operations.
Material Changes
The primary material change is the increase in outstanding share count and the infusion of capital via the registered direct offering. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
Management intends to utilize the net proceeds for general corporate purposes and working capital. The filing does not contain specific forward-looking guidance, updated financial outlook, or detailed risk factors beyond standard disclosures regarding the offering terms. The transaction was executed pursuant to a Registration Statement on Form S-3 (File No. 333-271567).
Key Facts for Investor Verification
- Verify the exact dilution impact on existing shareholders given the issuance of 313,564 shares plus the potential conversion of 1,979,769 Pre-Funded Warrants.
- Confirm the total gross proceeds raised by calculating the sum of the Common Stock and Pre-Funded Warrant sales to validate the $14.7 million net figure against the 7% placement fee and other expenses.
- Review the attached Securities Purchase Agreement (Exhibit 10.1) and Placement Agent Agreement (Exhibit 10.2) for specific covenants or restrictions.
- Monitor the exercise of the Pre-Funded Warrants to determine the final share count and cash inflow.